Navigation Links
PM's science prize for Ian Frazer
Date:10/17/2008

UQ's cervical cancer vaccine co-creator Professor Ian Frazer has won the 2008 Prime Minister's Prize for Science.

Professor Frazer, Director of UQ's Diamantina Institute for Cancer, Immunology and Metabolic Medicine, was presented with his prize by Prime Minister Kevin Rudd at a special ceremony in the Great Hall, Parliament House Canberra tonight (Thursday, October 16) .

The Prime Minister's Prize for Science is the nation's pre-eminent award for excellence in science and acknowledges the contributions of Australian scientists to economic and social wellbeing in Australia and the world.

Awarded for an outstanding specific achievement in any area of science advancing human welfare or benefiting society, it can encompass the physical, chemical, biological and technological sciences, mathematics and/or engineering.

The Prime Minister's Prize for Science comprises a grant of $300,000. The winner also serves on the Prime Minister's Science, Engineering and Innovation Council for a year.

Professor Frazer said he would donate his prize money to the University for a research program to develop further vaccines.

Last month, Professor Frazer, 2006 Australian of the Year and inaugural winner of the Queensland Smart State Premier's Fellowship in 2006, was announced as the winner of the Balzan Prize for International Medicine.

Together with his late research partner Dr Jian Zhou, Professor Frazer contributed to the development of a vaccine for cervical cancer.

"I'm honoured to be chosen as the 2008 recipient of the Prime Minister's Prize for Science, and delighted at the recognition of the contribution of science to the community that this prize makes," Professor Frazer said.

"I will use the opportunity granted by my selection to further the promotion of science as the best approach to solving the many challenges we face in society, in areas as diverse as health and the environment."

Since the vaccine's global application in 2006, more than 40 million doses have been administered to women and girls in more than 90 countries.

Acting UQ Vice-Chancellor Professor Michael Keniger congratulated Professor Frazer and said the Prime Minister had made an excellent choice

"As well as being a brilliant scientist whose work has a global impact, Professor Frazer has an infectious enthusiasm for the benefits of research and never tires in spreading the word to Australians and people all over the world," Professor Keniger said.

The vaccine protects against about 70 percent of human papillomavirus-related cervical cancers, with more than 270,000 women previously dying each year from the disease.

UQ now has two Prime Minister's Prize for Science recipients the other being Professor Mandyam Srinivasan, who won the award in 2006, just prior to his appointment to UQ as Head of Visual Neuroscience within the Queensland Brain Institute.


'/>"/>

Contact: Shirley Glaister
communications@uq.edu.au
61-733-651-931
Research Australia
Source:Eurekalert

Related medicine news :

1. Video: The Science Behind the Soak - a Coping Tool for Todays Changing World
2. Albany College of Pharmacy and Health Sciences - New Name, Same Commitment to the Advancement of Health Care
3. Breaking News: Finally! A Catholic Bishop Confirms that a Catholic Cannot Vote for Obama in Good Conscience
4. Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs
5. NuView Life Sciences Inc. Assumes Management of Trace Life Sciences Inc. Radioisotope Production Facility
6. Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging
7. Intellect Neurosciences, Inc. Grants to Top Tier Global Pharmaceutical Company an Option to License Certain Alzheimers Patents and Patent Applications
8. Managing Gas Isn't Rocket Science
9. ProGenTech Targets Clinical Diagnostics and Applied Sciences Markets with Human Genetic Signatures Deal
10. Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
11. Gene Network Sciences Announces Drug Development Collaboration with Biogen Idec
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... 2016 , ... The West Virginia Medical Institute (WVMI) announced ... name change aligns the entire company with its existing Quality Insights branded projects ... are very proud of the achievements associated with the West Virginia Medical Institute ...
(Date:12/8/2016)... ... December 08, 2016 , ... After enjoying ... opened registration today for its 33rd Annual Issues & Research Conference, March ... The theme of the conference is “Persistent Challenges and New Opportunities: Using Research ...
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , a New ... Conventional Data Capture Methods for Input to Electronic Health Records: A Comparative Usability ... the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) using ZyDoc’s ...
(Date:12/8/2016)... ... December 08, 2016 , ... Mirixa Corporation ... adherence, and other pharmacist-delivered patient care services, has announced the promotions of Karen ... to vice president of sales. , Litsinger joined Mirixa in 2008 after ...
(Date:12/8/2016)... ... 2016 , ... With the increasing demand for dental implants, the National Association ... to inform dentists and patients about the safety issues related to dental restorations. According ... the U.S. is projected to reach $6.4 billion in 2018 with more than 30 ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Eli Lilly and Company (NYSE: ... phase 3 EXPEDITION3 trial at the 9 th ... disclosed, solanezumab did not meet the primary endpoint in ... in people with mild dementia due to Alzheimer,s disease ... solanezumab for the treatment of mild dementia due to ...
(Date:12/8/2016)... -- Research and Markets has announced the addition of ... Type, Application, Usability - Forecast to 2025" report to their ... , , ... to grow at a CAGR of around 3.2% from 2015 to ... include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research in ...
(Date:12/8/2016)...   TriNetX , the health research network, ... signed a membership agreement to join the network ... cures. The TriNetX network is comprised ... globally, biopharmaceutical companies and contract research organizations (CROs) ... site selection, patient recruitment, and collaborative research across ...
Breaking Medicine Technology: